(E)-5-(2-Bromovinyl)pyrimidine-2,4(1H,3H)-dione
| Title | Journal |
|---|---|
| Relationships among plasma [2-(13)C]uracil concentrations, breath (13)CO(2) expiration, and dihydropyrimidine dehydrogenase (DPD) activity in the liver in normal and dpd-deficient dogs. | Drug metabolism and disposition: the biological fate of chemicals 20050301 |
| [Molecular toxicological mechanism of the lethal interactions of the new antiviral drug, sorivudine, with 5-fluorouracil prodrugs and genetic deficiency of dihydropyrimidine dehydrogenase]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20020801 |
| Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase. | Molecular pharmacology 20020501 |
| Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine. | Journal of medicinal chemistry 19860201 |